Landscape analysis of alternative splicing in kidney renal clear cell carcinoma and their clinical significance
- Songtao Cheng 1, Zili Zhou 2, Jiannan Liu 1, Jun Li 1, Yu Wang 1, Jiantao Xiao 3, Yongwen Luo 3
- Songtao Cheng 1, Zili Zhou 2, Jiannan Liu 1
- 1Department of Urology, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
- 2Department of Gastrointestinal Surgery, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, China.
- 3Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China.
- 0Department of Urology, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Alternative splicing (AS) plays a role in kidney renal clear cell carcinoma (KIRC). This study identifies AS signatures and develops a predictive model to improve KIRC patient prognosis and management.
Area Of Science
- Oncology
- Molecular Biology
- Bioinformatics
Background
- Alternative splicing (AS) is increasingly recognized for its role in cancer development, progression, and metastasis.
- A comprehensive analysis of AS signatures in kidney renal clear cell carcinoma (KIRC) is currently lacking.
- Understanding the AS landscape in KIRC is crucial for improving patient outcomes.
Purpose Of The Study
- To investigate the alternative splicing landscape in kidney renal clear cell carcinoma (KIRC).
- To identify and validate alternative splicing events and splicing factors as predictive biomarkers for KIRC prognosis.
- To develop a novel predictive model for enhancing the prognostic accuracy of KIRC.
Main Methods
- Utilized The Cancer Genome Atlas (TCGA) database for clinical data and gene expression profiles of KIRC patients.
- Analyzed seven types of alternative splicing events and identified prognostic-associated AS events using Cox regression analysis.
- Employed LASSO Cox regression to construct predictive models and the Metascape database for pathway analysis. Performed in vitro experiments to validate splicing factor roles.
Main Results
- Identified 46,276 alternative splicing events across 10,577 genes in KIRC.
- Discovered 5,864 prognostic-associated AS events and 34 prognostic-associated splicing factors (SFs).
- Developed predictive models with excellent prognostic accuracy for KIRC, validated the role of SF FMR1 in vitro.
Conclusions
- This study provides a comprehensive overview of the AS landscape in KIRC.
- Identified novel AS-based prognostic signatures to improve survival prediction for KIRC patients.
- The findings may facilitate personalized management and counseling for KIRC patients.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
02:18
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
01:32
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...

